Longwood Capital Partners »

Praxis Precision Medicines I shares owned by Longwood Capital Partners

Quarter-by-quarter ownership of Praxis Precision Medicines I shares owned by Longwood Capital Partners from 13F filings

Historical chart of Longwood Capital Partners investment in Praxis Precision Medicines I

Tip: Access up to 7 years of quarterly data

All positions including Praxis Precision Medicines I held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Praxis Precision Medicines I by Longwood Capital Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $7.7M 4.5M 1.71
2023-06-30 $4.9M 4.3M 1.15
2021-03-31 $5.1M 154k 32.76
2020-12-31 $4.2M 76k 55.02

More positions owned by Longwood Capital Partners

Replimune Group Call Option (REPL)
Sarepta Therapeutics Call Option (SRPT)
Taysha Gene Therapies Com Shs (TSHA)
Apellis Pharmaceuticals (APLS)
Aadi Bioscience (AADI)
Praxis Precision Medicines I
Rayzebio
Rocket Pharmaceuticals (RCKT)
Ventyx Biosciences (VTYX)
Disc Medicine (IRON)
Kura Oncology (KURA)
Cymabay Therapeutics
Vaxcyte (PCVX)
Immunovant (IMVT)
Syndax Pharmaceuticals (SNDX)

View all positions for Longwood Capital Partners

Top funds holding Praxis Precision Medicines I

Sphera Funds Management
Baker Bros. Advisors

View all funds holding Praxis Precision Medicines I